AVTR

Avantor, Inc.

Healthcare · $10.2B market cap

Verdict

Share price

$15.34

close of Oct 3, 2026

Fair value

$18.88

Sticker Price

Payback Price

$7.55

buy price

Undervalued

AVTR is Undervalued: at $15.34 it trades 19% below its fair value of $18.88. Its buy price (Payback Price) is $7.55, 51% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew -4% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth7.9% a year✗
Equity per share growth7.2% a year✗
Sales growth10.6% a year✓
Free cash flow growth24.4% a year✓
Return on invested capital3.5%✗

Follow AVTR

Get notified when it reaches its buy price of $7.55. Free.

Create a free account

Superinvestors

5 of the investors we track hold AVTR. In Q2 2026, 1 added and 1 sold out. Who we track

Moves in Q2 2026

Added: Mason Hawkins

Sold out: Lee Ainslie

Insider activity

Since Jun 21, 2026: no open-market purchases and 5 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

About Avantor, Inc.

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The…

Medical - Instruments & Supplies

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works